Live Oak Health Sciences Fund
Live Oak Health Sciences Fund (LOGSX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
logsx · pe ratio · data through Jun 14, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Asset Management · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Live Oak Health Sciences FundYou LOGSX | $49M | N/A | — | — |
 Appleseed Fund APPLX | $36M | N/A | — | $0.00 |
 Emerald Finance and Banking Innovation Fund FFBFX | $44M | N/A | — | — |
 Nuveen Large Cap Select Fund FLRYX | $51M | N/A | — | — |
 AMF Large Cap Equity Fund IICAX | $54M | 2.36x | — | $4.47 |
 Matrix Advisors Dividend Fund MADFX | $65M | N/A | — | — |
 Monetta Young Investor Growth Fund MYIFX | $46M | N/A | — | $0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Live Oak Health Sciences Fund (LOGSX) measures how much investors pay for each dollar of the company's trailing earnings. LOGSX's current PE ratio of N/A is calculated by dividing its stock price of $24.17 by its TTM earnings per share of —.
Frequently asked questions
LOGSX pe ratio · 6 questionsLOGSX's current PE ratio is N/A as of 2026-06-14, based on a stock price of $24.17 and TTM EPS of —. Data sourced from Financial Modeling Prep via LOGSX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Live Oak Health Sciences Fund SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-14